Holen Sie sich die Stockscreener-App
4.59
10.10%
0.43
Handel nachbörslich:
4.59
Schlusskurs vom Vortag:
$4.16
Offen:
$4.18
24-Stunden-Volumen:
331.49K
Relative Volume:
1.09
Marktkapitalisierung:
$96.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-94.11M
KGV:
-0.7637
EPS:
-6.01
Netto-Cashflow:
$-86.06M
1W Leistung:
-7.29%
1M Leistung:
+51.66%
6M Leistung:
+33.53%
1J Leistung:
-40.75%
1-Tages-Spanne:
$4.10
$4.6099
1-Wochen-Bereich:
$4.10
$5.59
52-Wochen-Spanne:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Firmenname
Adverum Biotechnologies Inc
Sektor
Branche
Telefon
(650) 649-1004
Adresse
100 CARDINAL WAY, REDWOOD CITY, CA
Vergleichen Sie ADVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.59 | 87.29M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-07 | Hochstufung | Truist | Hold → Buy |
| 2021-07-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Herabstufung | Truist | Buy → Hold |
| 2020-12-16 | Eingeleitet | UBS | Neutral |
| 2020-11-12 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-05 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-10 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-09-13 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-06-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-11-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Eingeleitet | SunTrust | Buy |
| 2018-02-15 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten
Does Adverum Biotechnologies Inc. (AVU0) stock trade below intrinsic valueRisk Management & Technical Confirmation Alerts - newser.com
What MACD trends signal for Adverum Biotechnologies Inc. (AVU0) stock2025 Key Lessons & Growth Focused Entry Reports - newser.com
What’s the recovery path for long term holders of Adverum Biotechnologies Inc.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Will Adverum Biotechnologies Inc. stock return to pre crisis levelsIPO Watch & Real-Time Chart Pattern Alerts - newser.com
Using RSI to spot recovery in Adverum Biotechnologies Inc.July 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Does Adverum Biotechnologies Inc. fit your quant trading model2025 Pullback Review & Real-Time Stock Price Movement Reports - newser.com
Analyzing recovery setups for Adverum Biotechnologies Inc. investorsShare Buyback & Real-Time Volume Spike Alerts - newser.com
Is Adverum Biotechnologies Inc. stock attractive for growth ETFs2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Real time social sentiment graph for Adverum Biotechnologies Inc.GDP Growth & Reliable Intraday Trade Plans - newser.com
Can Adverum Biotechnologies Inc. (AVU0) stock sustain revenue momentumGap Up & Smart Allocation Stock Tips - newser.com
Price action breakdown for Adverum Biotechnologies Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Can Adverum Biotechnologies Inc. recover in the next quarterAnalyst Upgrade & Expert Curated Trade Setups - newser.com
Adverum Biotechnologies Inc.’s volatility index tracking explainedFed Meeting & High Conviction Trade Alerts - newser.com
Adverum Biotechnologies (NASDAQ:ADVM) Stock Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Visual trend scoring systems applied to Adverum Biotechnologies Inc.Market Sentiment Review & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for Adverum Biotechnologies Inc.Earnings Overview Summary & Safe Entry Trade Signal Reports - newser.com
Adverum Biotechnologies' (ADVM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Is Adverum Biotechnologies Inc. (AVU0) stock a buy during volatile marketsGlobal Markets & Technical Buy Zone Confirmations - newser.com
Will Adverum Biotechnologies Inc. stock gain from lower inflationWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Using data filters to optimize entry into Adverum Biotechnologies Inc.July 2025 Summary & Verified Technical Signals - newser.com
Adverum Biotechnologies Inc Stock Analysis and ForecastShort Interest Overview & Explosive Profit Potential - earlytimes.in
What technical models suggest about Adverum Biotechnologies Inc.’s comebackWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Should you wait for a breakout in Adverum Biotechnologies Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - newser.com
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Will Adverum Biotechnologies Inc. stock go up soon2025 AllTime Highs & Safe Capital Growth Tips - newser.com
After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year - Yahoo Finance
What drives Adverum Biotechnologies Inc stock priceInstitutional Holding Changes & Smarter Trades Backed by Machine Learning - earlytimes.in
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adverum Biotechnologies Inc-Aktie (ADVM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):